Cargando…

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis

Inhibition of aldehyde dehydrogenase 1 family member A3 (ALDH1A3) has been revealed to lead to significant increase of microRNA (miR)-7 expression and decrease of CD44 expression in breast cancer stem cells (BCSCs), however the mechanism is not clear. The aim of the present study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Meng, Li, Miao, Guo, Mei, Zhou, Huiying, Xu, Hui, Zhao, Fengshu, Mei, Feng, Xue, Rui, Dou, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383762/ https://www.ncbi.nlm.nih.gov/pubmed/34504547 http://dx.doi.org/10.3892/etm.2021.10527

Ejemplares similares

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
por: Lee, Jia-Lin, et al.
Publicado: (2009)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

CD44 modulates Smad1 activation in the BMP-7 signaling pathway
por: Peterson, Richard S., et al.
Publicado: (2004)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
por: Pham, Phuc V, et al.
Publicado: (2011)

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Another Notch in CD44
por: Dove, Alan W.
Publicado: (2001)

CD44 in rheumatoid arthritis
por: Naor, David, et al.
Publicado: (2003)

Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation
por: Pan, Meng, et al.
Publicado: (2019)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
por: Okamoto, Isamu, et al.
Publicado: (2001)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
por: Cirillo, Nicola
Publicado: (2023)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S
por: Kong, Lingwei, et al.
Publicado: (2022)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Publicado: (1991)

Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis
por: Liu, Qing, et al.
Publicado: (2020)

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition
por: Gao, Yuan, et al.
Publicado: (2015)

CD44's nuclear road trip
por: Leslie, Mitch
Publicado: (2009)

A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid
Publicado: (1996)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway
por: Zhou, Bin, et al.
Publicado: (2018)

The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)

Conservation of CD44 exon v3 functional elements in mammals
por: Vela, Elena, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rsf4lu7mcogddbq4fc88sefdku